<DOC>
	<DOCNO>NCT00939783</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety tolerability Dimebon patient Alzheimer 's disease .</brief_summary>
	<brief_title>An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer 's Disease</brief_title>
	<detailed_description>This study terminate May 7 , 2010 part modification dimebon development plan follow lack demonstration efficacy complete DIM14 ( CONNECTION ) Study . The study terminate due safety finding . Dimebon well -tolerated clinical trial . Demonstration efficacy dimebon Alzheimer 's disease pending completion ongoing DIM18 ( CONCERT ) Study .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Completion previous Phase 3 Dimebon study ( B1451027 ) . Have severe acute chronic medical psychiatric condition laboratory abnormality may increase risk associate study participation investigational product administration may interfere interpretation study result , judgment investigator , would make patient inappropriate entry study .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>